Wednesday, September 27, 2023
Home Tags Vildagliptin Plus

Tag: Vildagliptin Plus

Medicine
Industry

Cipla acquires rights for anti-diabetic drug in India

The Health Master -
New Delhi: Homegrown pharma major Cipla Ltd said it has acquired brand name and trademark rights for Vysov for anti-diabetic drugVildagliptin for the Indian market from Novartis. However, it didn't disclose...

Latest posts

Govt Job
Govt Job Alert

Govt Job: For Technical Officer Positions at ICMR

The Health Master -
Govt Job Govt Job: Are you a qualified professional seeking an exciting career opportunity? Look no further! The...
USFDA

USFDA issued Positive EIR to Gland Pharma: Hyderabad

Medicine

Anti-TB Drugs: Urgent appeal to address critical shortage in India

Laboratory lab

India’s Pharma-MedTech Sector: New Policy and Scheme unveiled for transforming

Health Lady

Lung Health for breathing easy: Nationwide Initiative launched

USFDA Approval

USFDA approval granted for Icosapent Ethyl capsules

Laboratory lab

Quality Control in Pharma: Understanding the Significance of Dissolution Test

Govt Job

Govt Job: Opportunities for Project Associates at THSTI

USFDA Approval

USFDA approval granted for Norepinephrine Bitartrate Injection: A Breakthrough in Hypotensive...

Drug recall FDA

Drug Recall: Sucralfate Oral Suspension recalled due to this reason

ICMR

Antimicrobial Resistance in India: The Alarming Rise and Potential Solutions –...

CDSCO DCGI FDA

Govt Job: CDSCO Recruitment 2023 – Lucrative Opportunity

Medicine

5 Essential Benefits of Vitamin C Tablets You Should Know

Growth graph Increase rise

Booming Growth in Indian Pharma Exports: August 2023 Report

Workshop Pharma Training

Training of Technical Staff of Pharmaceutical Industry

Govt Job

Govt Job: For Junior Analyst in the Drugs Testing Laboratory, Pay...

USFDA Form 483

USFDA issues Form 483 observations to Cipla’s Subsidiary

Medicine Vaccine Injection

Phase I Clinical Trial permission Granted for Chickenpox Vaccine

Govt Job

Govt Job: For M.Pharm, MSc, M.Tech as Senior Research Fellow at...

Medicine

USFDA declines to approve Nasal Spray for allergic reactions

Lab microscope

Boost for Medical Device Testing: CDSCO approves Nine New Laboratories

CDSCO DCGI FDA

CDSCO and Jharkhand Govt host 3-Day Training program for Drug Regulators

Laboratory test chemical

Drug alert: 48 out of 1166 samples declared as NSQ in...

USFDA Form 483

USFDA issues Form 483 with one observation to Aurobindo

Authors

Rakesh Dahiya
111 POSTS0 COMMENTS
Nidhi Gudwani
40 POSTS0 COMMENTS
Lalit Kr. Goel
32 POSTS0 COMMENTS
N K Ahooja
15 POSTS0 COMMENTS
Dr. Kumud Madan
13 POSTS0 COMMENTS
Naripen Goyal
11 POSTS0 COMMENTS
Sushant Mahapatra
7 POSTS0 COMMENTS
Manmohan Taneja
5 POSTS0 COMMENTS
Dr. J K Jha
5 POSTS0 COMMENTS
Dr. Brahmdeep Sindhu
4 POSTS0 COMMENTS
Dr. B Suresh
4 POSTS0 COMMENTS
Dr. Bharatesh R Jagashetty
3 POSTS0 COMMENTS
H. Mahapatra
3 POSTS0 COMMENTS
Dr. P K Sreekumar
2 POSTS0 COMMENTS
Dr. NPS Verma
2 POSTS0 COMMENTS
Dr. Balraj Yadav
1 POSTS0 COMMENTS
Dr. BN Nagpal
1 POSTS0 COMMENTS
Adarsh Goyal
1 POSTS0 COMMENTS
P P Sharma
1 POSTS0 COMMENTS
Sanjay Malhotra
1 POSTS0 COMMENTS
http://www.aerolgroup.com
P K Jaggi
1 POSTS0 COMMENTS

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

© The Health Master. All rights reserved.